ARTICLE | Emerging Company Profile
Noxxon: The Martian Chronicles
June 29, 1998 7:00 AM UTC
Noxxon Pharma's palindromic name perfectly reflects its technology, which is itself a reflection of biology. All living organisms have evolved to use one chiral form, or handedness, of a given molecule - Noxxon is taking advantage of the dual nature of protein and nucleic acid chemistry to develop mirror image molecules to address biological targets.
"We identify mirror image nucleic acids with functional properties by combining molecular evolution and rational design," said CEO Jens Fürste...